CAR T, immunotherapy bring new hope for multiple myeloma patients – EurekAlert (press release)
Endpoints News |
CAR T, immunotherapy bring new hope for multiple myeloma patients
EurekAlert (press release) PHILADELPHIA – Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the treatment of multiple myeloma patients who had relapsed and were resistant to other therapies … 'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 … |
